Michel Pavic
Overview
Explore the profile of Michel Pavic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Page P, Dastous S, Richard P, Pavic M, Nishimura T, Riazalhosseini Y, et al.
Cancer Cell Int
. 2025 Feb;
25(1):71.
PMID: 40016765
Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is one of the first truncal events in clear cell Renal Cell Carcinoma (ccRCC) tumorigenesis. The accumulation of Hypoxia Induced Factor...
2.
Tremblay D, Joly-Mischlich T, Dufour A, Battista M, Berbiche D, Cote J, et al.
JMIR Res Protoc
. 2025 Jan;
14:e63099.
PMID: 39832166
Background: Telehomecare monitoring (TM) in patients with cancer is a complex intervention. Research shows variations in the benefits and challenges TM brings to equitable access to care, the therapeutic relationship,...
3.
Rajadurai C, Gagnon G, Allard C, Malick M, Pavic M
Curr Oncol
. 2024 Nov;
31(11):7040-7050.
PMID: 39590149
Background: Immunotherapy is the cornerstone of treatment for many cancers. The effectiveness of immunotherapy in hospitalized patients is unknown due to the exclusion of this fragile population from clinical trials....
4.
Pouliot F, Saad F, Rousseau E, Richard P, Zamanian A, Probst S, et al.
J Nucl Med
. 2024 Sep;
65(11):1710-1717.
PMID: 39327017
Intrapatient intermetastatic heterogeneity (IIH) has been demonstrated in metastatic castration-resistant prostate cancer (mCRPC) patients and is of the utmost importance for radiopharmaceutical therapy (RPT) eligibility. This study was designed to...
5.
Chen A, Turcotte A, Higgins S, Pavic M, Ethier V, Levesque Dion V
Case Rep Nephrol
. 2024 Sep;
2024:5556426.
PMID: 39301111
Introduction: Monoclonal gammopathy of renal significance (MGRS) is a rare entity describing patients with renal impairment related to the secretion of immunoglobulins without hematological criteria for treatment of a specific...
6.
Tessier C, LeBlanc R, Roy J, Trudel S, Cote J, Lalancette M, et al.
Cancer Med
. 2024 Sep;
13(17):e70192.
PMID: 39225552
Background: Plasma cell leukemia (PCL) is a rare monoclonal gammopathy, associated with short survival. Because of its very low incidence, only a few cohorts have been reported and thus, information...
7.
Parent-Roberge H, Fontvieille A, Poirier L, Tai L, Pavic M, Fulop T, et al.
Brain Behav Immun Health
. 2024 Aug;
40:100825.
PMID: 39155952
Background: It has been suggested that the acute natural killer (NK) cell response to aerobic exercise might contribute to the tumor suppressor effect of regular exercise observed in preclinical studies....
8.
Toure M, Sfairy S, Bedard S, McFadden N, Hanel R, Lemay F, et al.
Qual Life Res
. 2024 Apr;
33(6):1605-1619.
PMID: 38642218
Background: Because health resources are limited, health programs should be compared to allow the most efficient ones to emerge. To that aim, health utility instruments have been developed to allow...
9.
Fontvieille A, Parent-Roberge H, Fulop T, Pavic M, Riesco E
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473351
Cancer-related fatigue (CRF) is a prevalent and persistent issue affecting cancer patients, with a broad impact on their quality of life even years after treatment completion. The precise mechanisms underlying...
10.
Moria F, Park C, Eigl B, Macfarlane R, Pavic M, Saleh R
Curr Oncol
. 2024 Feb;
31(2):704-722.
PMID: 38392046
Locally advanced or metastatic urothelial carcinoma (aUC) presents a significant challenge with high mortality rates. Platinum-based chemotherapy remains the established frontline standard of care, and a switch-maintenance strategy with immunotherapy...